Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

Kidney International

Volumn 58, Issue 1, 2000, Pages 353-362

  Cheung, Alfred K ^a,b   Sarnak, Mark J ^a   Yan, Guofen ^a   Dwyer, Johanna T ^a   Heyka, Robert J ^a   Rocco, Michael V ^a   Teehan, Brendan P ^a   Levey, Andrew S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Coronary risk factors; Dialysis; Serum total cholesterol; Uremia; Vascular disease

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONICITY; CORONARY RISK; FEMALE; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UREMIA;

EID: 0033937001     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00173.x     Document Type: Article

References (28)

1. 1. U.S. RENAL DATA SYSTEM: USRDS 1998 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 1998
2. 2. ACOSTA JH: Hypertension in chronic renal disease. Kidney Int 22:702-712, 1982
3. 3. CHEUNG AK, WU L, KABLITZ C, LEYPOLDT JK: Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 22:271-276, 1993
4. 4. AVRAM MM, FEIN PA, ANTIGNANI A, MITTMAN N, MUSHNICK RA, LUSTIG AR, LAPUZ MH, GOLDWASSER P: Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med 87:55N-60N, 1989
5. 5. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 25:458-482, 1990
6. 6. ZAGER PG, NIKOLIC J, BROWN RH, CAMPBELL MA, HUNT WC, PETERSON D, VAN STONE J, LEVEY A, MEYER KB, KLAG MJ, JOHNSON HK, CLARK E, SADLER JH, TEREDESAI P: "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54:561-569, 1998
7. 7. EKNOYAN G, LEVEY AS, BECK GJ, AGODOA LY, DAUGIRDAS JT, KUSEK JW, LEVIN NW, SCHULMAN G: The hemodialysis (HEMO) Study: Rationale for selection of interventions. Semin Dial 9:24-33, 1996
8. 8. GREENFIELD S, APOLONE G, MCNEIL BJ, CLEARY PD: The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: Comorbidity and outcomes after hip replacement. Med Care 31:141-154, 1993
9. 9. VENABLES WN, RIPLEY BD: Modern Applied Statistics with S-Plus. New York, Springer-Verlag, 1994
10. 10. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA 269:3015-3023, 1993
11. 11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2445, 1997
12. 12. MURABITO JM, EVANS JC, LARSON MG, LEVY D: Prognosis after the onset of coronary heart disease: An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 88:2548-2555, 1993
13. 13. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis 20:32-38, 1992
14. 14. ROSTAND SG, KIRK KA, RUTSKY EA: Dialysis-associated coronary heart disease: Insights from coronary angiography. Kidney Int 25: 653-659, 1984
15. 15. BLOEMBERGEN WE, PORT FK, MAUGER EA, WOLFE RA: Causes of death in dialysis patients: Racial and gender differences. J Am Soc Nephrol 5:1231-1242, 1994
16. 16. UBBINK JB, VERMAAK WJH, DELPORT R, VAN DER MERVWE A, BECKER PJ, POTGIETER H: Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 62:802-808, 1995
17. 17. SCHREINER PJ: Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: The Atherosclerosis Risk in Communities (ARIC) Study. Chem Phys Lipids 67-68:405-410, 1994
18. 18. MARTIN MJ, HULLEY SB, BROWNER WS, KULLER LH, WENTWORTH D: Serum cholesterol, blood pressure, and mortality: Implication from a cohort of 361,662 men. Lancet 2:933-936, 1986
19. 19. KANNEL WB, GORDON T, SCHWARTZ MJ: Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 27:335-345, 1971
20. 20. PORT FK, HULBERT-SHEARON TE, WOLFE RA, BLOEMBERGEN WE, GOLPER TA, AGODOA LYC, YOUNG EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33:507-517, 1999
21. 21. FLETCHER AE, BULPITT CJ: How far should blood pressure be lowered? N Engl J Med 326:251-254, 1992
22. 22. CRUICKSHANK JM, THORP JM, ZACHARIAS FJ: Benefits and potential harm of lowering high blood pressure. Lancet 2:581-584, 1987
23. 23. ISEKI K, FUKIYAMA K: Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672-1675, 1996
24. 24. BRITTAIN E: Probability of coronary heart disease developing. West J Med 136:86-89, 1982
25. 25. Coronary Risk Handbook: Estimating Risk of Coronary Heart Disease in Daily Practice. New York, American Heart Association, 1973
26. 26. PARFREY PS, FOLEY RN, HARNETT JD, KENT GM, MURRAY D, BARRE PE: Outcome and risk factors of coronary heart disease in chronic uremia. Kidney Int 49:1428-1434, 1996
27. 27. ROSTAND SG, GRETES JC, KIRK KA, RUTSKY EA, ANDREOLI TE: Coronary heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600-611, 1979
28. 28. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl):S112-S119, 1998